Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing.  Medicare Part B reimbursement policies relating to clinical diagnostic testing; generally support Section 216 of Protecting Access to Medicare Act (H.R. 4302) relating to adjustments to the Medicare Clinical Laboratory Fee Schedule; oppose reductions to Medicare Clinical Laboratory Fee Schedule. Affordable Care Act and its impact on clinical laboratories and laboratory personnel; legislation concerning regulation of laboratory-developed diagnostic tests.
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
STONE MATTHEIS XENOPOULOS AND BREW, PC
1025 THOMAS JEFFERSON STREET, NW. #800 W, WASHINGTON, DC, 20007, US
MICHAEL N MCCARTY PATRICK BURCHETTE MICHAEL N MCCARTY PATRICK BURCHETTE